These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 365264)

  • 21. [Chronic/granulomatous disease and Kell blood-group].
    Ito K; Konishi H
    Nihon Rinsho; 1981 Jan; 39(1):190-4. PubMed ID: 7289050
    [No Abstract]   [Full Text] [Related]  

  • 22. Duffy, Kell and P blood group systems in some Jewish populations of Israel.
    Kobyliansky E; Micle S; Goldschmidt-Nathan M; Arensburg B; Nathan H
    Acta Anthropogenet; 1980; 4(3-4):173-9. PubMed ID: 7346047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kell and Xg gene frequencies in Algeria.
    Aireche H; Benabadji M
    Gene Geogr; 1995 Dec; 9(3):177-84. PubMed ID: 8740895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Kell blood group system and the McLeod phenotype.
    Redman CM; Marsh WL
    Semin Hematol; 1993 Jul; 30(3):209-18. PubMed ID: 8211224
    [No Abstract]   [Full Text] [Related]  

  • 25. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.
    Bansal I; Jeon HR; Hui SR; Calhoun BW; Manning DW; Kelly TJ; Lee S; Baron BW
    Vox Sang; 2008 Apr; 94(3):216-220. PubMed ID: 18167163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system.
    Clapéron A; Hattab C; Armand V; Trottier S; Bertrand O; Ouimet T
    Brain Res; 2007 May; 1147():12-24. PubMed ID: 17379193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic granulomatous disease, Kx negative neutrophils and linkage with Xg.
    Densen P; Wilkinson S; Mandell GL; Sullivan G; Oyen R; Marsh WL
    Adv Exp Med Biol; 1982; 141():655-8. PubMed ID: 7201230
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythrocyte morphology in genetic defects of the Rh and Kell blood group systems.
    Taswell HF; Lewis JC; Marsh WL; Wimer BM; Pineda AA; Brzica SM
    Mayo Clin Proc; 1977 Mar; 52(3):157-9. PubMed ID: 402512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auto analyzer determination of red cell Kell phenotypes in patients with chronic granulomatous disease (CGD) and heterozygous carriers.
    Bowell PJ; Hill FG
    Br J Haematol; 1978 Jul; 39(3):351-5. PubMed ID: 698113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic granulomatous disease and the Kell blood groups.
    Marsh WL; Oyen R; Nichols ME; Allen FH
    Br J Haematol; 1975 Feb; 29(2):247-62. PubMed ID: 1191546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease, McLeod syndrome and hyper-IgE. Case report.
    Kantar A; Oggiano N; Gabbianelli R; Fabrizzi G; Giorgi PL
    Minerva Pediatr; 1994 Apr; 46(4):157-60. PubMed ID: 8084323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A McLeod phenotype detected by random screening for K:-4 [Kp(b-)] blood donors in Brazil.
    Wendel S; Fontão-Wendel R; Levi JE; Aravechia MG; Bordokan RF; Russo D; Haddad MS
    Transfusion; 2004 Nov; 44(11):1579-87. PubMed ID: 15504163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haematological changes associated with the McLeod phenotype of the Kell blood group system.
    Wimer BM; Marsh WL; Taswell HF; Galey WR
    Br J Haematol; 1977 Jun; 36(2):219-24. PubMed ID: 871435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABO, MN, Kell, Hp and Gm1 markers in elderly humans.
    Turowska B; Gurda M; Woźniak K
    Mater Med Pol; 1991; 23(1):7-12. PubMed ID: 1843985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The distribution of some genetic polymorphisms in Italy].
    Piazza A; Olivetti E; Carbonara AO; Bargagna M; Pecori F; Benciolini P; Cortivo P; Breda F; Domenici R; Jayakar S
    Ric Clin Lab; 1982; Suppl 2():1-108. PubMed ID: 6818669
    [No Abstract]   [Full Text] [Related]  

  • 36. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease.
    Russo DC; Oyen R; Powell VI; Perry S; Hitchcock J; Redman CM; Reid ME
    Transfusion; 2000 Nov; 40(11):1371-5. PubMed ID: 11099667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The distribution of ABO, MNSs, Rhesus, Kell, Duffy and Kidd blood groups of Jews originating from 20 countries.
    Levene C; Medalie JH; Friedlander Y; Cohen T
    Isr J Med Sci; 1984 Jun; 20(6):509-18. PubMed ID: 6432728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Deficiency of erythrocyte antigens as a cause of pathology. III. Absence of antigens of the Kell system (KO)].
    Gómez Casal F; Poderós Baeta C; Soler Mantilla H; Romero Colás MS; Fuertes Palacio MA; Callén Sevilla L; Gutiérrez Martín M
    Rev Clin Esp; 1983 Oct; 171(1):23-5. PubMed ID: 6658078
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis.
    Ho MF; Chalmers RM; Davis MB; Harding AE; Monaco AP
    Ann Neurol; 1996 May; 39(5):672-5. PubMed ID: 8619554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kx antigen, the McLeod phenotype, and chronic granulomatous disease: further studies.
    Marsh WL; Oyen R; Nichols ME
    Vox Sang; 1976 Nov; 31(5):356-62. PubMed ID: 1007158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.